After Hours Summary: EBF +3.2%, SCS -20.1% following earnings/guidance; ALXA +41% following Phase 2a study resultsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings: EBF +3.2%, CTAS +1.0%
Companies trading higher in after hours in reaction to news: ALXA +41.2% (announced interim results of its Phase 2a study of AZ-002 in epilepsy patients; AZ-002 produced a dose-related decrease in mean SPR, the primary endpoint in the study), NTI +9.1% (entered into merger agreement with Western Refining (WNR); NTI unitholders will receive $15.00 in cash and 0.2986 of a share of WNR common stock for each NTI common unit held), BTU +7.6% (disclosed Wyoming Department of Environmental Qualit as completed its review of self-bonding related to permits that were under renewal; reaffirmed self-bonding eligibility for both permits), CYDY +3.7% (FDA cleared CytoDyn for relaxed entry criteria for its ongoing Phase 3 trial)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: SCS -20.1%, OFC -3.1%
Companies trading lower in after hours in reaction to news: RPRX -1.6% (reported that it believes topline results from all three of its ongoing Proellex studies, can be reported by the end of third quarter of 2016), NTAP -1.2% (acquired SolidFire for $870 mln in cash)